AML (Acute Myeloid Leukemia),Leukemia Venetoclax and Hypomethylating Agents vs HAG in AML May 20, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Targeted IGHV SHM in CLL for Prognosis Integration May 15, 2024
AML (Acute Myeloid Leukemia),Leukemia Efficacy of GO-Based AML Treatment: Low vs. Intermediate Risk May 15, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Enhancing CAR T-Cell Therapy in Leukemia: Beyond CD22 May 14, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Optimal PEGasparaginase Dosing for Infants With ALL May 14, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Impact of CLO in Adult ALL: Survival Insights May 10, 2024
AML (Acute Myeloid Leukemia),Leukemia Enhanced AML Treatment: VEN+AZA vs. AZA Monotherapy May 09, 2024
